Cara Ferreira

Chief of Staff at Fusion Pharmaceuticals

Dr. Ferreira brings a unique background of business strategy and radiopharmaceutical science to the Fusion Pharmaceuticals team. Prior to joining Fusion Pharmaceuticals, Dr. Ferreira was an Associate Partner at the global consulting firm McKinsey & Company where she was a leader in the Pharmaceutical Practice and the Healthcare Investing Service Line. During her time at McKinsey, Dr. Ferreira advised pharmaceutical and biotechnology companies on a range of topics include corporate strategy, innovation, portfolio optimization, acquisitions and in-licensing, and new product launch. She also advised private equity on investment opportunities in the healthcare and pharmaceutical space.

Previously, she was a Senior Development Officer in the R&D group of Nordion (division acquired by BWXT), a global leader in medical isotopes and radiopharmaceuticals. At Nordion, Dr. Ferreira lead research in diagnostic and therapeutic radiopharmaceuticals both internally and through numerous external collaborations with industry and academia. Active in the nuclear medicine community, Dr. Ferreira has held numerous elected positions with the Society of Nuclear Medicine and Molecular Imaging including President of the Radiopharmaceuticals Science Council and member of the House of Delegates.

Dr. Ferreira holds a PhD in radiochemistry and an MBA in strategic management for the University of British Columbia.

Links

Timeline

  • Chief of Staff

    November, 2020 - present

View in org chart